Payward filed for regulatory approval on 16 September to offer US-regulated perpetual futures on the Hyperliquid on-chain platform, according to industry coverage. If approved, the arrangement would produce something the US market does not yet have: a live, regulated perpetual futures venue whose settlement and matching infrastructure runs on-chain rather than through a conventional clearing and matching stack. The application is not a small compliance filing. It is an attempt to formalise a new venue category, and the response from regulators will define the shape of on-chain derivatives access for US clients.
Perpetuals have been the missing piece in the US crypto derivatives menu
Perpetual futures are the dominant derivative product across global crypto markets and they are essentially unavailable to US retail and most US professional clients under the current framework. That gap has been visible for years, and it has produced two market phenomena. The first is US clients using offshore venues through varying levels of workaround to access perpetuals. The second is a persistent demand signal that a US-regulated perpetuals product would answer immediately if the regulatory path could be found.
Payward's filing takes a specific approach to that path. Rather than trying to relitigate whether perpetuals should be available to US retail, the application proposes a US-regulated version of the product on an on-chain venue. That framing lets the regulator engage with a product design rather than with a policy question, and product designs are easier to negotiate than policy questions. Whether the design actually clears is a separate matter, and the industry will read the timeline of the response as an indicator of how the regulator views the whole space.
The design choice to build on Hyperliquid specifically is significant. Hyperliquid has spent the last eighteen months building a reputation as a professional-grade on-chain derivatives venue, with volume and liquidity metrics that compare credibly to established centralised venues in the same product line. That reputation is the argument the application makes on the regulator's behalf: an on-chain venue can be operationally credible enough that regulating it is a reasonable act, not an experiment.
What approval would actually change
If the filing clears, the immediate change is that US clients would have a compliant path to a product category they have been reaching for through less compliant channels. That has direct commercial value for Payward and for Hyperliquid, and it has indirect commercial value for every US client who prefers to keep their trading inside a regulated envelope. Neither of those groups is small.
The structural change is bigger. An on-chain venue operating under US derivatives regulation becomes a proof point that regulated venues do not have to look like the traditional exchanges the current framework was designed around. That opens conceptual space for other on-chain venues to seek similar approvals, for other product categories to be constructed on similar architectures, and for the overall regulatory framework to develop a working relationship with on-chain infrastructure that the current framework has mostly avoided. A single approval does not accomplish all of that. It creates the precedent that the following approvals build on.
The counterparties who will find this change most difficult are the offshore venues that have been serving US clients through the workaround approach. If a US-regulated perpetuals venue is available, the case for a US client to use an offshore alternative weakens sharply. Some of that flow will migrate, and offshore venues that had built US-serving strategies without a compliance backbone will find those strategies harder to sustain. That is not necessarily a bad outcome for the market. It concentrates the volume on venues that can be held accountable when things go wrong.
- US retail and professional demand for perpetuals has been persistent and largely unmet
- Payward's filing frames the question as a product design rather than a policy debate
- Hyperliquid's operational reputation carries the credibility argument on the regulator's behalf
- Approval would open conceptual space for other on-chain venue applications
- Offshore venues serving US clients through workarounds face reduced strategic space
The dependencies that could delay or block approval
It is worth being honest about the reasons a filing of this kind might not clear on the current timeline. The CFTC and the SEC have not fully resolved jurisdictional questions around perpetuals, and the current framework's tolerance for on-chain settlement infrastructure is genuinely uncertain. A regulator that wants to approve the application still has to work through provisions on custody, on segregation of client funds, on market surveillance, and on the systemic implications of an on-chain venue holding US-regulated positions. None of those are trivial, and any of them can extend a review indefinitely.
The shelved CLARITY Act makes some of those questions harder to answer, because the legislative framework that would have simplified the jurisdictional map is no longer in prospect. Regulators approving novel arrangements under the existing framework carry more institutional risk than they would under a clearer statutory basis, which means they proceed more cautiously, which means the timeline for the Payward filing is likely to be longer than the industry hopes for.
That is not a reason for the applicant to withdraw, and there is no indication it will. It is a reason for the market to expect the review to take quarters rather than months, and to build the strategic response around that timeline rather than around an optimistic reading of it. Firms competing for the same client base that would benefit from the approval should not wait for the approval to move. The client demand is real now, and the operators who serve it best in the intermediate period are the ones who will hold the client relationships when the regulated version arrives.
An on-chain venue operating under US derivatives regulation becomes a proof point that regulated venues do not have to look like the traditional exchanges the current framework was designed around.
The Asian read on a US on-chain derivatives approval
For Asian venues and Asian regulators, a US on-chain derivatives approval would be a meaningful data point that shapes the domestic conversation about on-chain infrastructure in regulated markets. Singapore's MAS, Hong Kong's SFC and Japan's FSA have all been developing views on the specific question of how on-chain venues fit into their regulatory frameworks, and a US precedent, positive or negative, would enter those conversations quickly.
The likely regional response is not immediate mimicry. Asian regulators typically observe developments in the US and EU carefully, extract the parts that fit their own regulatory philosophy, and construct their own version rather than adopting foreign precedents wholesale. What a US approval would do is remove some of the intellectual barriers that currently make it easier for Asian regulators to say no to comparable local applications, and that shift is worth more strategically than the direct effect of the US decision itself.
What did Payward file for?
US regulatory approval to offer regulated perpetual futures on the Hyperliquid on-chain platform, filed on 16 September 2026.
Why does the venue choice matter?
Hyperliquid has built a reputation as a professional-grade on-chain derivatives venue with credible volume and liquidity metrics. That operational credibility supports the argument that the application is about a product design rather than a policy debate.
How long might approval take?
Given the novelty of the arrangement and the unresolved jurisdictional questions in the current framework, the review is likely to be measured in quarters rather than months.
What happens if it is approved?
US clients gain a compliant path to a product they have been reaching for through less compliant channels, and the regulatory framework establishes a precedent for on-chain venues operating inside its perimeter.
Regulatory approvals of novel arrangements are the slow, unglamorous decisions that shape market structure for years, and the Payward filing is a serious attempt to secure one. The outcome will be watched by every operator considering on-chain infrastructure for regulated products, by every offshore venue serving US clients through arrangements that would look worse in comparison to an approved alternative, and by every Asian regulator quietly developing their own view on how on-chain venues fit into their frameworks. The decision the US regulators eventually make will do work far beyond the immediate scope of the application, and the applicants who understand that are the ones building the strongest cases regardless of how the specific filing lands. The specific things worth watching over the coming quarters are the review timeline, the specific conditions any approval carries, and the response of the offshore venues that would be most affected by an approved US-regulated on-chain derivatives destination. Each of those provides forward-looking information the industry will use to calibrate its own moves, and the firms doing that calibration in real time will be positioned earlier than the firms that wait for the decision itself. The wait, either way, is unlikely to be short, and the strategic value of moving early is meaningful across the intervening period. Firms that treat the filing as a signal about direction rather than as an event to await are already planning the products, partnerships and jurisdictional positioning that the eventual approval would validate.
Speak with the SpinDepth desk
